ACG San Diego BrownBag | Secrets to Navigating the Funding and Exit Landscape for Life Sciences and Healthcare Companies in 2023

ACG San Diego BrownBag Series

Event Details


March 21, 2023 11:30 AM - 1 PM PDT

Add to Calendar



Secrets to Navigating the Funding and Exit Landscape for Life Sciences and Healthcare Companies in 2023

In this uncertain economy, we will discuss how to navigate the funding and exit landscape for companies operating in the key sectors of life sciences and healthcare. Our panel will be asked to share their insights on who is investing, investors’ behind-the-scenes decision-making processes, and what those deals could look like when the ink dries.

From the other side of the table, we will discuss some of the practical steps that companies can take in 2023 to best prepare, position and present themselves for the opportunities that exist. 

Lastly, we will discuss general life science and healthcare investing trends that either follow or diverge from what we are seeing in other key sectors of the economy.


David Crean

David Crean

Cardiff Advisory
Managing General Partner

David has +25 years buy- and sell-side expertise of M&A, partnering and investments within the life sciences and healthcare sectors working within strategic biopharmaceutical companies, private equity, investment banking and venture capital. He serves as Managing Partner for Cardiff Advisory LLC, a boutique mergers & acquisitions investment banking and strategic advisory firm focused on M&A and partnering collaborations for life sciences and healthcare companies.

In parallel to his investment banking activities, David is an emerging fund manager and raising capital for Coast BioVentures, a life sciences fund focused on the Southern California market.  He is also a venture partner for Suncoast Ventures and a limited partner for Mesa Verde Venture Partners, two life sciences venture funds focused on incubator through growth-stage companies.


Ken Weixel

Procopio Business Advisors, LLC
Senior Growth Advisor

Ken Weixel, the former Managing Partner of the San Diego, California, office of Deloitte LLP, brings decades of experience working with life sciences and healthcare companies of all sizes and in all stages of growth as a trusted advisor on corporate governance, effective controls, mergers and acquisitions and transparent financial reporting. During his seven years leading Deloitte’s San Diego office, Weixel helped to expand its operation from 200 to more than 450 professionals, guiding it to become the largest accounting firm in San Diego. He took the reins of the San Diego office in 2014 tasked in part with growing its Life Sciences practice, given his decades of work with that industry, having previously served in leadership positions with Deloitte’s Life Science and Healthcare industry practices.

Weixel received his B.S. in Accounting from Capital University in 1980. He is also a graduate of the Columbia University Graduate School of Business Leadership and the Wharton School of Executive Leadership. Weixel has served on the Boards of Biocom, the California Chamber of Commerce and the Century Club of San Diego, and also served on the Executive Committee of the United Way of San Diego County. He previously served on the Board and the Executive Committee of Capital University, where he chaired the Audit, Finance and Human Resources Committees. Since 2016 Weixel has been recognized as one of San Diego’s top 500 Influential Business Leaders in the San Diego Business Journal SD 500.

Derek Brunelle

Derek Brunelle

Synthase Capital Partners, LLC
Founder, Managing Director

Derek R. Brunelle is the founder and managing director of Synthase Capital Partners and has worked in the venture backed technology, healthcare, and life science ecosystems for over fifteen years in senior leadership roles at Silicon Valley Bank and J.P. Morgan. Derek has structured and placed over $500 million in debt capital to private and public companies in the hardware, software, biotech, med. device, and pharma sectors.

Derek earned his B.S in Business Administration from the University of Vermont. 

Helen Goldstein

Helen Goldstein (Moderator)

Procopio, Cory, Hargreaves & Savitch LLP

Helen Goldstein is an associate on the firm’s Business & Technology team. She maintains a general cross-industry practice, but has experience advising companies that transact in highly regulated or intellectual property rich environments, such as life sciences and healthcare. Helen is a trusted advisor to her clients providing support whether it is “business as usual” or when executing key transactions including financings, acquisitions, exits, and leadership transitions.

Overall, Helen has a reputation for building creative transactional structures, prioritizes a collaborative approach, and drives her client’s agendas forward efficiently and effectively.

Event Secondary Body


  • ACG Members: $30
  • Non-Members & Guests: $40

(Includes boxed lunch)


For more BrownBag info: 

Please contact BrownBag Chair Jessica Lazur at or 619-525-3846.     


Please Note: Your registration for this event acts as an audio/video release and includes your permission for ACG San Diego to use your image and comments captured on audio, video or photographic formats while attending the event for marketing and promotional purposes. For further information please contact or 619-741-7247.

Hosted by: ACG
San Diego